Germany - Open framework agreement on drug discounts in accordance with Section 130a (8) sentence 1 SGB V with the option to join at any time, so-called approval model 2024-07
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 05 July 2026
- Opportunity publication date
- 05 July 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The purpose of this announcement is to conclude agreements with pharmaceutical companies within the meaning of Section 130a (8) sentence 1 of the German Social Code, Fifth Book (SGB V) (discount agreements). In accordance with Section 130a (8) sentence 1 SGB V, the invitation to participate is only directed at pharmaceutical companies or employee associations of pharmaceutical companies within the meaning of Section 4 (18) of the German Medicines Act (AMG). It is not an open procedure, but a publication of the invitation to conclude/join discount agreements with fixed and non-negotiable conditions for all participants, including the amount of the discount. An unlimited number of pharmaceutical companies or employee associations of pharmaceutical companies within the meaning of Section 4 (18) of the German Medicines Act (AMG) may become contracting parties. The contract is concluded or an accession is made by completing the required self-declarations or evidence and the contract(s) either
a) signed by hand (written form in accordance with Section 126 BGB) by post or
b) sent to the CAB by e-mail to openhouse.rabattvertrag2024-07@kbs.de with a qualified electronic signature (Section 126a BGB).
The earliest start of the contract is 01.09.2024, provided that the contract and the required declarations or evidence have been received by the CAB by 05.08.2024 at the latest. The start of the contract is therefore the 1st of the month following the month in which the contract and the required declarations or evidence are received by the CAB, provided that they are received by the 5th of each month; otherwise the 1st of the month after next. The contracts end automatically, without the need for termination, as soon as contractual partners for the active ingredient(s) or combination(s) of active ingredients have been determined by means of a formal award procedure. The closing date for the receipt of accessions is 05.07.2026. In any case, the contracts end on 31.08.2026.
The active ingredients/active ingredient combinations can be found in the attachment "Advertisement text".
The link to the contract documents can be requested by e-mail (openhouse.rabattvertrag2024-07@kbs.de). The documents will be made available on the CAB homepage.
- Opportunity closing date
- 05 July 2026
- Value of contract
- to be confirmed
About the buyer
- Address
- Deutsche Rentenversicherung Knappschaft-Bahn-See, Abteilung IX – Recht, Compliance, Dezernat IX.1.1 - Vergabestelle, Wasserstr. 215, 44799 Bochum
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.